1159908-44-7
Chemical Structure
N-Arachidonylglycine-d8
Synonym(s): NA-Gly-d8
- CAS No.: 1159908-44-7
- Formula:C22H27D8NO3
- Molecular Weight:369.57
IUPAC Name: ((5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl-5,6,8,9,11,12,14,15-d8)glycine
InChIKey: YLEARPUNMCCKMP-FBFLGLDDSA-N
SMILES: OC(CNC(CCC/C([2H])=C([2H])\C/C([2H])=C([2H])\C/C([2H])=C([2H])\C/C([2H])=C([2H])\CCCCC)=O)=O
Biological Activity:
N-Arachidonylglycine-d8 is a deuterated labeled N-Arachidonylglycine[1]. N-Arachidonylglycine (NA-Gly), a carboxylic analog of the endocannabinoid anandamide (AEA), is a GPR18 agonist (EC50 = 44.5 nM). Unlike AEA, N-Arachidonylglycine has no activity at either CB1 or CB2 receptors. N-Arachidonylglycine inhibits GLYT2 (IC50 = 5.1 μM). N-Arachidonylglycine also is an effective activator of endometrial cell migration[2][3].
The product specifications provided below refer solely to the active content of N-Arachidonylglycine-d8.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
N-Arachidonylglycine-d8 | 98.1% | N-Arachidonylglycine-d8 is a deuterated labeled N-Arachidonylglycine. N-Arachidonylglycine (NA-Gly), a carboxylic analog of the endocannabinoid anandamide (AEA), is a GPR18 agonist (EC50 = 44.5 nM). Unlike AEA, N-Arachidonylglycine has no activity at either CB1 or CB2 receptors. N-Arachidonylglycine inhibits GLYT2 (IC50 = 5.1 μM). N-Arachidonylglycine also is an effective activator of endometrial cell migration. The product specifications provided below refer solely to the active content of N-Arachidonylglycine-d8. |
||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
N-Arachidonylglycine | 99.45% | N-Arachidonylglycine (NA-Gly), a carboxylic analog of the endocannabinoid anandamide (AEA), is a GPR18 agonist (EC50 = 44.5 nM). Unlike AEA, N-Arachidonylglycine has no activity at either CB1 or CB2 receptors. N-Arachidonylglycine inhibits GLYT2 (IC50 = 5.1 μM). N-Arachidonylglycine also is an effective activator of endometrial cell migration. The product specifications provided below refer solely to the active content of N-Arachidonylglycine. |
||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.88
HY-175470Stearidonoyl glycine -
Similarity Score 0.88
HY-103507N-Arachidonyl-GABA -
Similarity Score 0.87
HY-10863Anandamide -
Similarity Score 0.87
HY-N16008C20:4 Anandamide (AEA) -
Similarity Score 0.86
HY-134545N-Arachidonoyl-L-alanine -
Similarity Score 0.86
HY-119352S-2 Methanandamide -
Similarity Score 0.86
HY-123594R-2 Methanandamide -
Similarity Score 0.86
HY-117141N-Arachidonoyl-3-hydroxy-γ-aminobutyric acid -
Similarity Score 0.85
HY-110004ACEA -
Explore the MedChemAI to find more analogs
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]
- [2]. McHugh D, et al. Δ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells. Br J Pharmacol. 2012;165(8):2414-2424. [Content Brief]
- [3]. Edington AR, et al. Extracellular loops 2 and 4 of GLYT2 are required for N-arachidonylglycine inhibition of glycine transport. J Biol Chem. 2009;284(52):36424-36430. [Content Brief]
